Yokota K, Takenouchi T, Fujisawa Y, Fukushima S, et al. Long-term follow-up results from KEYNOTE-041: Phase 1b study of pembrolizumab in Japanese patients with advanced melanoma. J Dermatol 2024 Mar 26. doi: 10.1111/1346-8138.17002.
PMID: 38529706